Literature DB >> 19428359

Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines.

Alexander Bauer1, Anika Schumann, Matthias Gilbert, Christian Wilhelm, Jan G Hengstler, Jürgen Schiller, Beate Fuchs.   

Abstract

Carbon tetrachloride (CCl(4)) represents an excellent model to study oxidative injury of cells. It is widely accepted that hepatocellular injury is a consequence of the metabolic conversion of CCl(4) into highly reactive, free radical intermediates. Among the direct toxic effects of CCl(4), stimulation of lipid peroxidation and the binding of the electrophilic radicals to membrane lipids have been suggested to play important roles in the pathogenesis of irreversible cell damage. CCl(4)-induced liver damage was modeled in cultures of rat hepatocytes with the focus on alterations of phosphatidylcholine (PC). The PC acyl chain composition was analyzed by (31)P NMR spectroscopy and MALDI-TOF mass spectrometry. The content of the membrane arachidonoyl PC was decreased by almost 30% after incubation of the cells with CCl(4). This relative decrease was found to correlate with increased concentrations of the corresponding saturated lysophosphatidylcholine (LPC). It is concluded that LPC represents a useful biomarker of CCl(4)-mediated damaging of hepatocytes. It is also speculated that de novo biosynthesis of PC is influenced by CCl(4).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428359     DOI: 10.1016/j.chemphyslip.2009.02.006

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  2 in total

Review 1.  Principles of multiparametric optimization for phospholipidomics by 31P NMR spectroscopy.

Authors:  Norbert W Lutz; Patrick J Cozzone
Journal:  Biophys Rev       Date:  2013-02-26

2.  Advances in 2D and 3D in vitro systems for hepatotoxicity testing.

Authors:  Seddik Hammad
Journal:  EXCLI J       Date:  2013-11-28       Impact factor: 4.068

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.